Skip to main content

Table 4 Estimated power calculation for CRP reduction between 50 and 75% in the active treatment group is shown, evaluated with 3 different standard deviation (SD) values

From: Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)

Power analysis CRP reduction
(estimated mean 7.64 mg/l)
N = 28 50% 55% 60% 65% 70% 75%
SD 3.37 mg/l 85% 91% 95% 97% 99%  > 99%
SD 3.74 mg/l 77% 84% 90% 94% 97% 98%
SD 4.11 mg/l 69% 77% 84% 89% 93% 96%